| 中文名称: | 1-((2R,3R,4S,5R)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-基)-5-(羟甲基)嘧啶-2,4(1H,3H)-二酮 |
| 中文别名: | 5-羟基甲基尿苷;5-羟甲基尿苷;5-羟甲基-尿苷;1-((2R,3R,4S,5R)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-基)-5-(羟甲基)嘧啶-2,4(1H,3H)-二酮 |
| smiles: | OCC1C(=O)NC(=O)N(C2OC(CO)C(O)C2O)C=1 |
| 英文名称: | 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-(hydroxymethyl)pyrimidine-2,4(1H,3H)-dione |
| 英文别名: | Uridine,5-(hydroxymethyl)- (6CI,7CI,8CI,9CI);5-(Hydroxymethyl)uridine;5-Hydroxymethyluridine;2-Hydroxymethylthiophene-5-carboxylic acid ethyl ester;5-hydroxymethyl-thiophene-2-carboxylic acid ethyl ester;5-Hydroxymethyl-uridin;5-hydroxymethyl-uridine;ethyl 5-hydroxymethylthiophene-2-carboxylate;MB07582;SureCN2653117;Uridin-5-methanol;AKOS027339888;A848737;5-Hydroxymethyl ?uridine;30414-00-7;1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(hydroxymethyl)-1,2,3,4-tetrahydropyrimidine-2,4-dione;4-Hydroxy-5-(hydroxymethyl)-1-pentofuranosylpyrimidin-2(1H)-one;F12671;DTXSID00952752;SCHEMBL263750;MFCD00057401;CHEBI:165841;1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-(hydroxymethyl)pyrimidine-2,4(1H,3H)-dione;1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(hydroxymethyl)pyrimidine-2,4-dione;5-(hydroxymethyl)uridine;1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-(hydroxymethyl)pyrimidine-2,4-dione;1-((2S,3S,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-5-(hydroxymethyl)pyrimidine-2,4(1H,3H)-dione; |
| CAS号: | 30414-00-7 |
| 分子式: | C10H14N2O7 |
| 分子量: | 274.23 |
| 密度: | |
| 熔点: | |
| 沸点: | |
| 闪点: | |
| 水溶性: | |
| 蒸气压: |
1-((2R,3R,4S,5R)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-基)-5-(羟甲基)嘧啶-2,4(1H,3H)-二酮
英文名:
1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-(hydroxymethyl)pyrimidine-2,4(1H,3H)-dione
别名:5-羟基甲基尿苷;5-羟甲基尿苷;5-羟甲基-尿苷;1-((2R,3R,4S,5R)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-基)-5-(羟甲基)嘧啶-2,4(1H,3H)-二酮
商品编号:R144184-250mg
规格:250mg
纯度:97%
CAS号: 30414-00-7
分子式:C10H14N2O7
分子量:274.23
| 价格 |
¥ 1174.00
(请 登录 会员查看折扣价)
|
| 货期 | 5~7个工作日 |
数量
搜索质检报告(COA)
搜索MSDS
相关产品


















